Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05039073 |
| Title | Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Emory University |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Emory University Hospital/Winship Cancer Institute | RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
| Emory Saint Joseph's Hospital | RECRUITING | Atlanta | Georgia | 30342 | United States | Details |